International Society for NeuroVirology

Information
Scientific Forums
Related Links
Member LInks
Graduate Programs
Member Web Pages
Postdoctoral Positions Available

ISNV Home Page


The following International Society for NeuroVirology members maintain web pages which describe their professional qualifications, research interests, and departmental/organizational affiliations. For more information, click on the member's name.

  • Dr. Brian Wigdahl - Transcriptional regulation of retroviruses within cells of the CNS
  • Dr. Igor J. Koralnik - Basic science interests - immunopathogenesis of JC virus in progressive multifocal leukoencepahlopathy; Clinical interests: neurologic manifestations of HIV infection. Director of the HIV/Neurology Center.
  • Dr. Kenneth Tyler - Research Interests: NF-kappaB, TRAIL, microarray, myocarditis, caspase-activation, cell cycle, Y2H, and neuronal apoptosis
  • Dr. Robert Fujinami - Studies of viral pathogenesis using an animal model for the human demyelinating disease known as multiple sclerosis
  • Dr. Nigel Fraser - HSV-1 latency, the role of the immune system in limiting the spread of HSV, development of gene therapy vector systems for use in the nervous system
  • Dr. Walter Atwood - Studies of JC virus (JCV) and HIV-1 pathogenesis in the human central nervous system
  • Dr. E. Antonio Chiocca - Gene transfer technologies and applications to disorders of the central nervous system
  • Dr. Atze T. Das - A member of the Berkhout research group; research interests include HIV-1 vaccine development using a tetracycline-dependent HIV-1 molecular clone
  • Dr. John Fazakerley - viral CNS infections, transmissible spongiform encephalopathies, and viral apoptosis.
  • Dr. Harris Gelbard - Major research interests include (i) the effects of chronic inflammation on neuronal signal transduction, as well as dendrito- and synaptogenesis in the mammalian nervous system, (ii) human immunodeficiency virus type 1 (HIV-1) infection as a model for oxidative stress and programmed cell death in the CNS, and (iii) interactions between dopamine and glutamate in the developing and adult nervous system.
  • Dr. Clinton Jones - Research interests include herpesvirus latency viral gene expression and regulation of cell cycle by herpesvirus and mycotoxins.
  • Dr. William Karpus - Studies in his laboratory focus on the pathogenesis and regulation of autoimmune encephalomyelitis (EAE), an animal model of human multiple sclerosis (MS).
  • Dr. Peter G. E. Kennedy - His main interest is in neurovirology, especially Varicella zoster virus (VZV) latency in the human nervous system.  His group has recently defined unambiguously the cellular location of latent VZV in human ganglia and has also carried out a major study of VZV gene expression during ganglionic latency.  His other main interest is in African trypanosomiasis (sleeping sickness), with close collaboration with Professor Max Murray's group in the Glasgow University's Department of Veterinary Clinical Studies.  The major interest is in understanding the pathogenesis of the post-treatment reactive encephalopathy using a mouse model, with the primary aim of developing more effective therapies for this condition.
  • Dr. Rick Meeker - Research interests include brain cholinergic receptors, vasopressin, AIDS research, HIV and FIV.
  • Dr. Richard J. Miller - Research interests include molecular pharmacology of receptors, signal transduction and synaptic transmission, regulation of neuronal receptors and ion channels, and molecular aspects of nerve cell degeneration.
  • Prof. V. Hugh Perry - Research efforts focus on inflammation in the CNS and its contribution to neurological disease.
  • Dr. Kenneth Tyler - His laboratory uses reoviruses as an experimental model system to investigate the role played by viral genes and proteins in pathogenesis and cell death and the signaling pathways by which this occurs.
  • Dr. Susan Weiss (alternate link)- Her lab is involved in the study of the murine coronavirus, mouse hepatitis virus (MHV). This virus is of importance in that infection of rodents with MHV provides one of the best model systems for the study of human demyelinating diseases such as Multiple Sclerosis.
  • Dr. Igor Koralnik - Dr. Koralnik is director of the HIV/Neurology Center, which offers comprehensive care for acute and chronic neurological problems in people with HIV infection or AIDS.
  • David B. Clifford, M.D. - Dr. Clifford has a broad interest in neuropharmacology. Development of more successful medical management of neurologic disease has been his clinical focus, and has included participation in studies of epilepsy, Parkinson's disease, multiple sclerosis, and virtually all neurologic complications of HIV.
  • Richard J. Frisque, Ph.D. - Dr. Frisque's laboratory’s research interests center on the unique biology of the human polyomavirus, JC virus (JCV).
  • Michael J. Buchmeier, Ph.D.  - Dr. Buchmeier's laboratory is interested in understanding the function(s) of viral glycoproteins and how these molecules interact with the host during infection. To understand functions of these proteins, he has utilized the murine coronavirus, mouse hepatitis virus (MHV), which encodes a large multifunctional spike glycoprotein, S, with receptor recognition, binding and membrane fusion activities.
  • Robert M. Levy, M.D., Ph.D. - Dr. Levy's current research efforts focus on examination of the blood brain barrier and novel methods of drug delivery to the central nervous system.
  • Professor S. Louise Cosby, Ph.D. - Present research concentrates on the neuropathogenesis of morbilliviruses and the basis of neurovirulence in viruses.
  • David M. Knipe, Ph.D. - Dr. Knipe's laboratory studies the mechanisms by which herpes simplex virus (HSV) undergoes a productive infection in epithelial cells versus a latent infection in neurons, the mechanisms of the host immune response to viral infection, and the use of mutant strains of HSV as a herpes vaccine and as a vaccine vector.
  • Gabriele Arendt, M.D. - (German site)
  • Gregory Atkins, Ph.D., D. Sc. - Dr. Atkins' laboratory is developing a new virus vector system based on the Semliki Forest virus (SFV) genome.
  • Xiaoli Yu, Ph.D. - Dr. Yu is a member of the Neurology Department at the University of Colorado Health Sciences Center.
  • Larisa Poluektova, Ph.D. - Dr. Poluektova is a member of the Center for Neurovirology and Neurodegenerative Disorders (CNND) at the University of Nebraska Medical Center.
  • Prof. Dr. med. Thomas Becker - Dr. Becker performs his research at the Abteilung Psychiatrie II
    der Universität Ulm.
  • Howard Fox, M.D., Ph.D. - Dr. Fox's laboratory is located at the Scripps Research Institute.
  • Susan Morgello, M.D. - Dr. Morgello conducts her research in the Fishberg Department of Neuroscience at the Mount Sinai School of Medicine.
  • Joanne Marcario, Ph.D. - Dr. Marcario's laboratory is located at the University of Kansas Medical Center.
  • M. Christine Zink, DVM, Ph.D. - Dr. Zink is a member of the Department of Comparative Medicine at the Johns Hopkins School of Medicine.
  • Elizabeth A. Hunsperger, Ph.D. - Dr. Hunsperger performs her research within the College of Veterinary Medicine and Biomedical Sciences at the Colorado State University.

ISNV members interested in publicizing their web sites on this page may submit their name, brief research description, and web site address (URL) to webmaster@isnv.org.